23andMe lays off over 100 employees.  Illumina comes to the JP Morgan empty-handed.  Has Precision Medicine seen it’s heyday already?  Or are we gearing up for another wave of innovation?  Nathan and Laura are again ready for the tough questions of genomics.

We begin with the current spat between genetic counselors and the ACMG.  Like, . . . huh? 

This is a public episode. If you’d like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

January 2020 Review: Genetic Counselors vs ACMG, 23andMe Layoffs, Privacy

Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine. 

www.mendelspod.com

Tech News

Technology

Natural Sciences

Science & Medicine

Social Sciences

Medicine

News

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

Sarah LeBaron von Baeyer studied anthropology at Yale. Today she serves as the Director of Ethics Engagement at the new drug development company, Variant Bio, not a job she ever imagined at university.

An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer

In today’s show, we talk with Kyle Fahr, the VP and Distinguished Scientist leading Illumina’s Artificial Intelligence Lab. "We lack a way of training genomics AI as readily as you would for natural language processing, says Fahr.  "There are vast amounts of data, but there are no labels, no supervision.  One of the most powerful tools that we’ve found is using clues from natural selection. Fahr says the company began the AI lab seven years ago when deep learning took off. Two of the team’s AI algorithms, PrimateAI-3D and SpliceAI, published in Cell and Nature Genetics, were among the first examples of deep learning algorithms in genomics to become widely used by clinical labs and researchers in interpreting variants of unknown significance.   We take a close look at Illumina’s work in AI and delve into the long-term impact of AI on genomics. 

This is a public episode. If you’d like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

Today, we continue our look into the gap in the adoption of precision medicine. Why are those who need it not getting genetic testing? Patrick Short is the Host of The Genetics Podcast and CEO and Co-founder of Sano Genetics.

The Pre-Symptomatic Space with Patrick Short, Sano Genetics

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

Through its Center for Personalized Medicine, the University of Colorado Health offers its 2.2 million patients some of the country's most advanced precision medicine initiatives.

Systemwide Implementation of Precision Medicine at UCHealth with David Kao

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

A  new spatial biology company is promising to shake up the field. Last month, Curio Bioscience launched a new technology to early access customers that provides transcriptomic spatial data without the need to b…

January 2020 Review: Genetic Counselors vs ACMG, 23andMe Layoffs, Privacy

Download our free app to listen on your phone